All News

Found 794,543 articles

• Sirna Therapeutics, Inc. Licenses Worldwide Exclusive Rights To microRNA Technology From University Of Massachusetts Medical School

  5/10/2006

• NephroGenex Licenses Pyridorin(TM) For Diabetic Nephropathy And Acute Renal Failure

  5/10/2006

• SurModics Inc. And Donaldson Announce Strategic Marketing And Distribution Relationship With Corning Life Sciences

  5/10/2006

• Aastrom Biosciences, Inc. Receives Manufacturing License At European Pilot Facility For Production Of Proprietary Bone Marrow Stem Cell Products

  5/10/2006

• Callisto Pharmaceuticals Selects EpiStem Ltd To Provide Specialised Preclinical Efficacy Testing For Guanilib, Its Lead Drug Candidate For IBD

  5/10/2006

• Ceragenix Pharmaceuticals, Inc. Enters Into Research Agreement With Johns Hopkins Burn Center To Evaluate Ceragenin(TM) Antimicrobial Wound Dressing

  5/10/2006

• Callisto Pharmaceuticals Announces Sponsored Research Agreement With M. D. Anderson Cancer Center To Further Development Of Degrasyn Anticancer Agents

  5/10/2006

• BrachySciences Advances Commitment To Brachytherapy With Exclusive TargetScan(R) Distribution Agreement

  5/10/2006

• Quigley Pharma Inc. To Commence Medical Feed Poultry Study For Its QR-441(a)

  5/10/2006

• Protein Discovery, Inc.'s PPS Silent(TM) Surfactant For Mass Spec Sample Prep Lyses Cells, Solubilizes Proteins, Degrades In Acid

  5/10/2006

• Novartis Corporation Release: Five Years After Approval, Gleevec Underscores The Promise Of Targeted Therapy To Provide Sustained Disease Control

  5/10/2006

• NanoLogix, Inc. Announces The Successful Conversion Of Welch's Waste Stream Into Usable Hydrogen

  5/10/2006

• Phylonix Pharmaceuticals, Inc. Issued Broad U.S. Patent For Screening Angiogenic Compounds Using Zebrafish

  5/10/2006

• Nanogen, Inc. Receives $25 Million Equity Financing Commitment

  5/10/2006

• Source Medical Solutions, Inc. Raises $16 Million

  5/10/2006

• Innovotech Inc. Subsidiary, MBEC BioProducts Inc. Receives $150,000 Phase 2 Technology Commercialization Award

  5/10/2006

• HeartWare Announce $32.5 Million Capital Raising

  5/10/2006

• QIAGEN Announces Exercise Of Over-Allotment Option - $300,000,000 of 3.25% Senior Convertible Notes Due 2026

  5/10/2006

• Emisphere Technologies, Inc. Announces Pricing Of Common Stock Offering

  5/10/2006

• Biosyntech Inc. Grants Stock Options

  5/10/2006